Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lazzarin

Showing results (341-350 of 384) with videos related to

Pageof 39
Sort By:
Annals of Internal Medicine|September 15, 1994
Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trialM Marroni, P Gresele, G Landonio, et al.
Journal of Biological Regulators and Homeostatic Agents|April 14, 2000
Viral dynamics and mutations in the pol gene during primary HIV-1 infectionA Cenci, A Bertoli, G Tambussi, et al.
Immunology Letters|June 1, 1996
HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infectionA Beretta, L Furci, S Burastero, et al.
AIDS Research and Human Retroviruses|March 1, 1996
Autoantibodies to CD4 in HIV type 1-exposed seronegative individualsS E Burastero, D Gaffi, L Lopalco, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2015
HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patientsN Gianotti, F Canducci, L Galli, et al.
HIV Medicine|June 23, 2018
In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infectionC Sagnelli, C Uberti-Foppa, H Hasson, et al.
Scientific Reports|December 5, 2020
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19V Spagnuolo, M Guffanti, L Galli, et al.
Scientific Reports|May 18, 2021
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19V Spagnuolo, M Guffanti, L Galli, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1997
Italian multicentre study of didanosine compassionate use in advanced HIV infection. Italian BMS-906 Study GroupA d'Arminio Monforte, M Musicco, M Galli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 19, 2015
Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trialM Ripa, M Pogliaghi, S Chiappetta, et al.
Pageof 39

Showing results (341-350 of 384) with videos related to

Sort By:
Pageof 39
Annals of Internal Medicine|September 15, 1994
Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trialM Marroni, P Gresele, G Landonio, et al.
Journal of Biological Regulators and Homeostatic Agents|April 14, 2000
Viral dynamics and mutations in the pol gene during primary HIV-1 infectionA Cenci, A Bertoli, G Tambussi, et al.
Immunology Letters|June 1, 1996
HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infectionA Beretta, L Furci, S Burastero, et al.
AIDS Research and Human Retroviruses|March 1, 1996
Autoantibodies to CD4 in HIV type 1-exposed seronegative individualsS E Burastero, D Gaffi, L Lopalco, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2015
HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patientsN Gianotti, F Canducci, L Galli, et al.
HIV Medicine|June 23, 2018
In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infectionC Sagnelli, C Uberti-Foppa, H Hasson, et al.
Scientific Reports|December 5, 2020
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19V Spagnuolo, M Guffanti, L Galli, et al.
Scientific Reports|May 18, 2021
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19V Spagnuolo, M Guffanti, L Galli, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1997
Italian multicentre study of didanosine compassionate use in advanced HIV infection. Italian BMS-906 Study GroupA d'Arminio Monforte, M Musicco, M Galli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 19, 2015
Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trialM Ripa, M Pogliaghi, S Chiappetta, et al.
Pageof 39